D. Lorne Tyrrell

RNA Virus Inhibitor Compounds and Uses Thereof

Compounds for the Treatment of Alzheimer's Disease

E1E2 HCV VACCINES AND METHODS OF USE

RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOF

ON-SITE VIRAL INACTIVATION AND RNA PRESERVATION OF GARGLE AND SALIVA SAMPLES COMBINED WITH DIRECT ANALYSIS OF SARS-COV-2 RNA ON MAGNETIC BEADS

RNA virus inhibitor compounds and uses thereof

E1E2 HCV VACCINES AND METHODS OF USE

Non-Peptidic Heterocycle-Containing Compounds for the Treatment of Alzheimer?s Disease

RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF

Compounds for the treatment of Alzheimer's disease

E1E2 HCV VACCINES AND METHODS OF USE

Biomarkers in autoimmune liver disease

Methods and compositions for treatment of autoimmune hepatitis

Methods of treatment of primary sclerosing cholangitis

E1E2 HCV VACCINES AND METHODS OF USE

Methods and compositions for diagnosis of inflammatory liver disease

Methods for producing cells having a phenotype of a primary human hepatocytes and compositions

Hepatitis B virus-binding polypeptides and methods of use thereof

Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection

Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection

Hepatitis B virus-binding polypeptides and methods of use thereof

Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection

Animal model having a chimeric human liver

Animal model having a chimeric human liver

Malarial animal model having a chimeric human liver